Equivalence Margin Definition

Equivalence margin definition establishes pre-specified limits defining acceptable performance differences between active comparator treatments in non-inferiority and equivalence trial designs. Margins derive from regulatory guidance, disease expert opinion, and analysis of historical active control trial effect sizes. Excessively wide margins permit inferior efficacy interpretation potentially compromising patient safety. Overly stringent margins increase sample size requirements and trial cost. Regulatory agencies carefully scrutinise margin justification ensuring scientific validity.

Non-inferiority margins typically represent 50 percent of historical active control effect sizes preserving therapeutic benefit. Margin selection fundamentally influences trial conclusion interpretation and regulatory acceptance. Sensitivity analyses examining alternate margins demonstrate conclusion robustness. Adaptive trial designs permit interim margin assessment with potential refinements based on accruing data. Statistical considerations including power calculations and population heterogeneity influence margin setting. FDA guidance emphasises conservative margin selection protecting patient interests.